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Aim: Measurement of health-related quality of life in people with dementia is a challenge, because of their special
characteristics and the difficulties that this term entails itself. The present study aimed at assessing the psychometric
properties of the EQ-5D rated by a familiar or a professional caregiver of institutionalized older adults with dementia.
Methods: We analyzed the EQ-5D psychometric properties from 525 questionnaires rated by proxy, in a sample of
institutionalized older adults with dementia.
Results: The mean EQ-5D index score was 0.11  0.38, and 51.54  21.47 for the visual analog scale. The
intraclass correlation coefficient was 0.72. Regarding internal consistency, Cronbach’s alpha was 0.64, and the
item-total correlation ranged from 0.33 to 0.53. Exploratory factor analysis identified a functional and a subjective
factor, accounting for 67.35% of the variance. Convergent validity of EQ-5D with Quality of Life Alzheimer’s Disease
by proxy and Quality of Life in Late-stage Dementia scales was satisfactory (r = 0.36–0.58). The EQ-5D showed
appropriate discriminative validity among patients grouped into several categories. Multiple linear regression models,
using EQ-index and visual analog scale as dependent variables, identified dependence level, proxy characteristics,
leisure and comorbidity as determinants of quality of life.
Conclusions: Despite some limitations in the more subjective dimensions, the proxy-rated EQ-5D showed satis-
factory psychometric properties in the present study, suggesting that it is a valid and alternative instrument to assess
quality of life in institutionalized older people with dementia. Geriatr Gerontol Int 2013; ••: ••–••.
Keywords: dementia, EQ-5D questionnaire, nursing homes, psychometric properties, quality of life.
Introduction
In the Quality of Life (QoL) assessment, participants
express the impact that the disease itself or the impact
the interventions and treatments have on their lives.
Assessing QoL in dementia is a challenge. There is not
a widely accepted gold standard for QoL. In addition,
subjective judgment is considered essential for measur-
ing QoL and, apparently it is not possible to obtain
reliable self-assessments in people with cognitive
impairment.1,2 Loss of memory and insight, and lower
ability for reasoning, elaborating judgment, and even for
managing language are usually present in dementia. It is
not clear at which point in the cognitive decline process
patients are no longer able to provide accurate self-
reports, and observational rating by proxy becomes nec-
essary. Some studies have found a good correlation
between self and proxy ratings, but, in contrast, they
also have detected that caregivers systematically give
lower ratings than patients themselves, with similar dif-
ferences between patients and caregivers for all levels of
impairment.1,3 To measure QoL in dementia, we count
on specific questionnaires, such as Quality of Life
Alzheimer’s Disease (QOL-AD)1 and Quality of Life in
Late-stage Dementia (QUALID),4 and also on generic
questionnaires, such as the EQ-5D.2,5,6
The EQ-5D is a standardized QoL and health status
instrument that offers a simple generic measure for both
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clinical and economic appraisal. Its advantages are that
it is an easy and quick to apply test, and it allows
researchers to evaluate and compare essential aspects of
health among groups and populations, and to deter-
mine the value of several health states. In addition, this
information can be used for cost-utility studies of spe-
cific programs and interventions for different patient
groups. The EQ-5D has been widely applied in the
general population,7–9 and is also suitable for patients
with cognitive impairment.2,5,6
Some studies assessing QoL in dementia exclude
patients with late-stage dementia, because it is difficult
to measure in this population.1,2,5,10 Besides, there is
scarce information about using the proxy mode of
administration of the EQ-5D instrument in patients
living in nursing homes.
The objective of the present study was to estimate
whether the EQ-5D rated by proxy is appropriate to
measure QoL in the special population of older adults
at any stage of dementia living in nursing homes.
Specifically, the psychometric properties of the EQ-5D
were analyzed. A secondary objective was to investi-
gate the association between some sociodemographic
and clinical characteristics of the patients, and their
QoL, using the information provided by the EQ-5D
by proxy.
Methods
Study design
The present cross-sectional study included 525 people
living in 14 nursing homes located in 10 different prov-
inces of Spain, and their usual caregivers. Patients had
to be aged at least 60 years, with a diagnosis of dementia,
according to the Diagnostic and Statistical Manual of
Mental Disorders, Fourth revision, Task Force (DSM-IV-
TR) classification,11 at any stage of severity. Written
informed consent was obtained from the patients them-
selves or their legal representative. Caregivers were a
near relative with regular, close contact with the patient,
familiar with his/her health status and behavior, or, in
case a family member was not available, a staff member
answered the questionnaire. All patients living in the
nursing homes that fulfilled inclusion criteria were con-
secutively recruited. The study was approved by the
institutional review board of the Carlos III Institute of
Health.
Assessments
Sociodemographic data of the patients were registered.
The following QoL measures were completed by the
caregiver: EQ-5D;7,9 QOL-AD;1,4 and QUALID.1,4
The Barthel Index,12–14 the Cornell Depression Scale,13,15
the number of chronic medical conditions,16,17
“Mini-Examen Cognoscitivo” (MEC; the Spanish
version of the MMSE)18,19 and the Clinical Dementia
Rating (CDR) scale20,21 were clinician rated.
The EQ-5D is a generic QoL and health status
instrument increasingly used in patients with neurologi-
cal disorders.2,3 It includes a section describing the
current health state in five dimensions (mobility,
self-care, usual activities, pain/discomfort, anxiety/
depression), using three levels of severity (1 = no prob-
lems; 2 = some or moderate problems; 3 = unable or
extreme problems). The five dimension scores can be
combined and 243 possible health states are thus
obtained. A utility index, ranging from -1 to +1, can be
calculated and assigned to each health state through an
algorithm. In the present study, the EQ-5D index based
on the time trade-off method and validated for the
Spanish population was used.8 The second part of the
EQ-5D consists of a visual analog scale (EQ-5D-VAS),
where the respondent marks the perceived current
health state from 0 (the worst imaginable state of health)
to 100 (the best possible state of health). Alternative
modes of administration for this instrument are avail-
able: self-completion form, asking participants to self-
rate their health; and proxy, asking a caregiver to rate
the participant’s health, used in the present study.9
Although there is an extended version of the EQ-5D
that includes a cognitive dimension (EQ-5D+C), the
study of Wolfs et al. did not find differences with the
EQ-5D in dementia patients.22 The recently introduced
EQ-5D-5L, which seems to improve sensitivity and
to reduce the ceiling effects of the test in respect to
EQ-5D, had not been validated for dementia patients,
neither for the Spanish population when the data for the
present study was collected.23,24
The QOL-AD is a specific instrument to measure
QoL in people diagnosed with Alzheimer’s disease
(AD).1,25 It includes 13 items (physical health, energy,
mood, living situation, memory, family, marriage,
friends, self, ability to do chores, ability to do things for
fun, money and life as a whole), rated from 1 (poor) to
4 (excellent). The sum score ranges from 13 to 52, with
lower scores indicating worse QoL.
The QUALID is aimed at measuring QoL in people
with severe dementia.1,4 The QUALID4,26 is composed
of 11 items (smiles, appears sad, cries, has a facial
expression of discomfort, appears physically uncomfort-
able, complaints, groans or screams, is irritable or
aggressive, enjoys eating, touching or being touched,
interacting or being with others, appears emotionally
calm and comfortable), each one scoring from 1 to 5,
with lower scores representing better QoL.
The Barthel Index measures the capacity to carry
out activities of daily living.12–14 The total score
ranges from 0 (total dependence) to 100 (total inde-
pendence). Ratings of 40 or less indicate severe
dependence.14
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The Cornell Depression Scale is a tool specifically
developed to assess depression in dementia patients.13,15
Scores 6 are indicative of a potential depressive
disorder.
The number of chronic medical conditions was
assessed through an adapted version of the Cumulative
Illness Rating Scale for Geriatrics.16,17 The questionnaire
inquires about the presence (yes/no) of 20 medical con-
ditions. The sum score of all positive responses was
dichotomized according to the median (7 medical con-
ditions in our sample).
Cognitive status was appraised using the “Mini-
Examen Cognoscitivo”, which is the adapted and vali-
dated version for Spain of the Folstein Mini-Mental
State Examination.18,19 It consists of 23 questions
scoring 35 as the maximum. In the present study, 23 out
of 24 was used as the cut-off point for the geriatric
population, and 14 as the cut-off point for severe cog-
nitive impairment.
The Clinical Dementia Rating scale was used to
evaluate the severity of dementia.20,21 The scale ranges
from 0 (no impairment) to 3 (severe dementia) in six
domains. Scores are combined to obtain a composite
score classifying dementia severity in stages: 1 (mild), 2
(moderate) or 3 (severe).20,21
Data analysis
Descriptive statistics were applied to define sociodemo-
graphic characteristics of our sample. The following
psychometric properties of the EQ-5D were explored.
Feasibility was assessed by means of the percentage of
missing data (maximum acceptable 10%) and fully com-
putable data (minimum acceptable 95%).2,27
Acceptability was estimated through score ranges
(observed vs possible), closeness of means to medians,
floor and ceiling effects (less than 15% of responses
accumulated at minimum or maximum values), and
skewness (between -1 and +1).27
For reliability, we calculated the internal consistency
through Cronbach’s alpha coefficient (standard crite-
rion 0.70), and the item-total correlation corrected for
overlap (ITCC; criterion 30).28 For interrater reliabil-
ity, we applied the EQ-5D to a subsample of 84 patients
and calculated the intraclass correlation coefficient
(ICC) with the caregiver’s responses (criterion >0.70).
To assess dimensionality and determine the factor
structure of the EQ-5D descriptive system, an explor-
atory factor analysis using a principal components
method with varimax rotation was carried out. Unidi-
mensionality was also assessed with Rasch analysis,29
carried out with RUMM2030 (Version 5.1 for
Windows, Perth, WA, Australia).
Convergent validity was examined using Pearson’s or
Spearman’s coefficients with specific scales for QoL in
dementia. We hypothesized that the EQ-5D would cor-
relate at a moderate (r = 0.35–0.50) or high (>0.50) level
with QOL-AD and QUALID proxy scales.30
Known-groups validity was explored by determining
the EQ-5D ability to distinguish among participants
grouped by variables of interest, using Student’s t-test
and ANOVA test. Answers to the EQ-5D dimensions
were grouped into two categories (no problems, any
problem) for this analysis.9 We hypothesized that
women would have significantly worse QoL than men,
and that QoL would decrease with age. We also
expected to find a lower QoL in people with lower
education level, lower functional status (no leisure and
lower Barthel Index), higher comorbidity, depression
and CDR score, and those whose EQ-5D was com-
pleted by a family member instead of a professional
caregiver.1,3,10,31 As contradictory findings have been
reported about the relationship between cognitive status
and QoL, we explored how EQ-5D varied by different
MEC levels.3,6,32,33
Two different multiple linear regression models
were carried out, one for the EQ-5D index and one for
the EQ-5D-VAS as dependent variables. The indepen-
dent variables entered in the model were: age, sex,
Barthel Index, Cornell Scale, CDR score, MEC, the
number of medical conditions, leisure and if the respon-
dent was a family member or a professional caregiver.
Multiple linear regression assumptions were previously
tested.
All calculations were carried out in SPSS 18 (SPSS,
Chicago, IL, USA), except regression analyses, which
were carried out with STATA 10 version for Windows
(Statacorp, College Station, TX, USA). The significance
level was set at 0.05.
Results
Descriptive statistics of sociodemographic charac-
teristics and applied rating scales are shown in
Table 1. The sample was composed mostly by women
(82.70%), with a mean age of 85.57 years. Most of the
patients were diagnosed with AD, 61.50% were clas-
sified as having severe dementia and almost 60% had
severe dependence. Nearly 60% of the patients were
classified as suffering from severe cognitive deteriora-
tion. Half of the people showed a high probability of
depression.
The average EQ-5D index was 0.11 (standard devia-
tion 0.38), and, the average EQ-5D-VAS was 51.54
(21.47). The distribution of responses by the three levels
of each EQ-5D dimension is presented in Figure 1.
There were less than 3% of lost values in EQ-5D
dimensions, index and VAS. Some dimensions showed
ceiling effects, whereas others had floor effects.
However, the EQ-5D index and EQ-5D-VAS did not
show floor or ceiling effects (Table 2).
EQ-5D by proxy in dementia
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The Cronbach’s alpha for the EQ-5D dimensions
was 0.64 and it rose to 0.68 when anxiety/depression
dimension was not considered, and to 0.75 when pain/
discomfort was also removed (Table 2). The ITCC
ranged from 0.21 to 0.53. The ICC was 0.72. The
exploratory factor analysis showed two different
factors, which accounted for 67.35% of the variance.
Factor 1 (functional area) was formed by mobility, self-
care and usual activities dimensions (item loadings on
this factor: 0.74, 0.85 and 0.85, respectively), and
factor 2 (subjective area) by pain/discomfort and
anxiety/depression (0.78 and 0.82). The lack of unidi-
mensionality of the EQ-5D was also confirmed by
Rasch analysis, showing a lack of fit to the Rasch
model.
Convergent validity of the EQ-5D index and VAS
with the QOL-AD and QUALID scales ranged from
0.36 to 0.58 in absolute values. Table 3 shows the mean
scores by subject groups for EQ-5D index, EQ-VAS
and each dimension of the instrument. Women and
older people scored significantly lower in the EQ-5D
index, whereas EQ-VAS presented lower values in those
with a lower education level and more comorbidity.
EQ-index and EQ-VAS scores were significantly lower
for people with higher CDR and lower Barthel Index,
and higher when the questionnaire was answered by a
staff member and for those patients who were engaged
in any kind of leisure.
In the multiple linear regression analysis (Table 4), the
Barthel Index was a significant determinant for both
EQ-5D index (standardized beta = 0.70) and EQ-5D-
VAS (0.26), followed by the type of informant (0.10
and 0.13 for EQ-5D index and VAS, respectively).
EQ-5D-VAS determinants were comorbidity (-0.23),
and practising active or cultural leisure (0.12 and 0.17,
respectively).
Table 1 Sociodemographic, clinical characteristics and applied rating scales
n (%) n (%)
Sociodemographic characteristics Mean  SD Clinical characteristics and rating scales Mean  SD
Sex (women) 434 (82.67) Proxy
Age (years) 85.57  6.73 Family member 128 (24.43)
Marital status Staff 396 (75.57)
Single 85 (16.28) No. medical conditions 7.75  2.80
Married 98 (18.77) CDR
Divorced 12 (2.30) Mild 72 (13.71)
Widowed 327 (62.64) Moderate 130 (24.76)
Education (less than primary) 343 (65.33) Severe 323 (61.52)
Years in nursing home 3.59 (3.21) MEC 13.24  8.07
Leisure activities Cornell scale 7.13  6.17
Active 185 (35.51) Barthel index 32.82  29.54
Passive 233 (44.47) EQ-5D index 0.11  0.38
Cultural 95 (18.13) EQ-5D-VAS 51.54  21.47
Social 144 (27.53) QOL-AD 27.26  5.14
QUALID 25.05  9.17
CDR, Clinical Dementia Rating; EQ-5D-VAS, EQ-5D visual analog scale; MEC, “Mini-Examen Cognoscitivo” (Spanish version
of the Mini-Mental State Examination); QOL-AD, Quality of Life in Alzheimer’s disease Scale; QUALID, Quality of Life in
Late-Stage Dementia Scale; SD, standard deviation.
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Figure 1 Proportions of EQ-5D dimensions responses. ( ),
Many problems, ( ) some problems, ( ), no problems.
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Discussion
The present study analyzed the psychometric properties
of the EQ-5D rated by proxy, and, despite some limita-
tions, it was found to be a valid and reliable tool to
measure QoL in institutionalized patients with different
stages of dementia. QoL was mainly related to patient’s
dependence level and comorbidity, the type of proxy
and participation in leisure activities.
Proxy ratings might improve the EQ-5D feasibility,
avoiding the loss of data of patients at advanced stages
of dementia who are unable to answer by themselves.
This finding is coincident with other studies that
showed fewer missing values with EQ-5D than with
QOL-AD in patient with severe cognitive impairment.2,3
The EQ-5D index showed good acceptability, with no
ceiling or floor effects, which is in line with other
works.3,6,34 Ceiling effects in functional dimensions
(mobility, self-care and usual activities) can be explained
by the high proportion of patients with severe depen-
dency in our sample. One of the limitations of using
proxy-rated scales is that the subjective component of
QoL could be partially lost,2,3,34 and this could explain
the floor effects shown in the pain/discomfort and
anxiety/depression dimensions.
Regarding the internal consistency, although ITCC
was adequate, the Cronbach’s alpha was moderate,
although it was higher when analyzing only directly
observable dimensions. This is consistent with the
exploratory factor analysis results, and could reflect the
multidimensional characteristic of the EQ-5D, measur-
ing complementary aspects of QoL. Besides, the ICC
showed a satisfactory reliability between EQ-5D proxy
and patient answers.1,3
Convergent validity of the EQ-5D index and EQ-5D-
VAS, with QOL-AD and QUALID, was good, as
hypothesized and in congruence with other works’
results.2,3 According to recognized criteria, we have
found significant differences between EQ-5D scores by
sociodemographics and clinical characteristics of the
analyzed population. Contrary to other studies,1,25,35
depression was not associated with the results of the
EQ-5D index or the EQ-VAS. One explanation for
this finding might be that proxies are less capable of
rating patients’ mood states than patients themselves.2,3
Whether the questionnaire was completed by a
professional instead of a family member showed a
positive significant effect over QoL, in line with other
studies.3,10
The most important determinant of EQ-5D value in
the present study was the functional status of the
patient, in agreement with the literature.6,10,31,36 The rela-
tionship between QoL and the severity of the disease, as
well as the cognitive function, was not maintained in the
multivariate model. Other studies have found contra-
dictory results regarding this.1,3,5,6,33 In our study, leisure
was a positive determinant of QoL. This finding corre-
sponds with those reported by Longsdon et al. when
using the QOL-AD; but less is known when it is
assessed by the EQ-5D.
The present results lead us to believe that more efforts
should be made to prevent functional dependence and
to maintain the autonomy of this frail population. The
Table 2 Feasibility, acceptability and reliability of EQ-5D
EQ-5D Dimensions
EQ-5D index EQ-5D-VAS Mobility Self-care Usual
activities
Pain/
discomfort
Anxiety/
depression
Missing (%) 11 (2.10) 15 (2.86) 10 (1.90) 8 (1.52) 8 (1.52) 7 (1.33) 8 (1.52)
Mean 0.11 51.54 – – – – –
Median 0.07 50.00 – – – – –
SD 0.39 21.47 – – – – –
Skewness 0.40 -0.09 -0.05 -1.26 -1.17 1.13 1.09
Minimum -0.65 0 1.00 1.00 1.00 1.00 1.00
Maximum 1.00 100 3.00 3.00 3.00 3.00 3.00
Floor effect (%) 2.10 1.20 21.40 3.30 5.40 64.30 62.50
Ceiling effect (%) 1.40 2.20 25.00 68.70 65.20 5.40 8.90
Cronbach’s alpha
(ITCC)
0.64 – (0.48) (0.53) (0.47) (0.33) (0.21)
Intraclass correlation
coefficient (ICC)
0.72 –
*Significant at 0.01 level (bilateral). For convergent validity, Pearson’s correlation coefficients for all but Quality of Life in
Late-Stage Dementia Scale (QUALID; Spearman). ITCC, item-total corrected correlation; SD, standard deviation; VAS, visual
analog scale. QOL-AD, Quality of Life in Alzheimer’s Disease Scale.
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present study suggests that the promotion of active and
cultural leisure activities among these patients would
increase their QoL. However, our findings about the
factors associated to QoL should be verified with lon-
gitudinal studies.
Although some specific instruments for QoL in
dementia, such as QOL-AD, had extensively shown
their utility in this population,1,25 the present study
shows that the EQ-5D, a simple and quick generic QoL
instrument, is a valid option to assess QoL in institu-
tionalized patients at different stages of dementia. The
use of a proxy rater contributed to increasing the feasi-
bility and acceptability of this tool. Other psychometric
advantages included a good interrater reliability,
adequate convergent validity with EQ-5D-VAS,
QOL-AD and QUALID, and good known-groups
validity. However, the EQ-5D by proxy has some weak-
nesses that have to be taken into account when applied
to institutionalized older adults with dementia: low
internal consistency and lack of unidimensionality, and
ceiling and floor effect for some dimensions (but not for
the EQ-5D index).
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